The first part of my dissertation focuses on post-randomization modification of intent-to-treat effects. For example, in the field of behavioral science, investigations involve the estimation of the effects of behavioral interventions on final outcomes for individuals stratified by post-randomization moderators measured during the early stages of the intervention (e.g., landmark analyses in cancer research). Motivated by this, we address several questions on the use of standard and causal approaches to assessing the modification of intent-to-treat effects of a randomized intervention by a post-randomization factor. First, we show analytically the bias of the estimators of the corresponding interaction and meaningful main effects for the st...
This dissertation presents three new methodologies for analyzing randomized controlled trials using ...
The aim of the thesis is to investigate how to optimize the design and analysis of randomized and no...
Nowadays, we are witnessing changes in the traditional clinical trial landscape: many methods have b...
The first part of my dissertation focuses on post-randomization modification of intent-to-treat effe...
The first part of my dissertation focuses on post-randomization modification of intent-to-treat effe...
Clinical trials are experiments tested on human to compare the effect of certain intervention. In ea...
In this dissertation, I consider inference about target parameters under three distinct study design...
Numerous human medical problems or diseases have been aided by the development of effective treatmen...
In observational studies, identifying assumptions may fail, often quietly and without notice, leadin...
In observational studies, identifying assumptions may fail, often quietly and without notice, leadin...
Thesis (Ph.D.)--University of Washington, 2021This dissertation comprises three projects that span t...
In the first project, we extend the nonparametric biased coin design (BCD) for studying a single age...
In randomized clinical trials where the effects of post-randomization factors are of interest, the s...
In this paper, we argue that causal effect models for realistic individualized treatment rules repre...
PhDRandomization schemes for two-treatment clinical trials are studied. Theoretical expressions for...
This dissertation presents three new methodologies for analyzing randomized controlled trials using ...
The aim of the thesis is to investigate how to optimize the design and analysis of randomized and no...
Nowadays, we are witnessing changes in the traditional clinical trial landscape: many methods have b...
The first part of my dissertation focuses on post-randomization modification of intent-to-treat effe...
The first part of my dissertation focuses on post-randomization modification of intent-to-treat effe...
Clinical trials are experiments tested on human to compare the effect of certain intervention. In ea...
In this dissertation, I consider inference about target parameters under three distinct study design...
Numerous human medical problems or diseases have been aided by the development of effective treatmen...
In observational studies, identifying assumptions may fail, often quietly and without notice, leadin...
In observational studies, identifying assumptions may fail, often quietly and without notice, leadin...
Thesis (Ph.D.)--University of Washington, 2021This dissertation comprises three projects that span t...
In the first project, we extend the nonparametric biased coin design (BCD) for studying a single age...
In randomized clinical trials where the effects of post-randomization factors are of interest, the s...
In this paper, we argue that causal effect models for realistic individualized treatment rules repre...
PhDRandomization schemes for two-treatment clinical trials are studied. Theoretical expressions for...
This dissertation presents three new methodologies for analyzing randomized controlled trials using ...
The aim of the thesis is to investigate how to optimize the design and analysis of randomized and no...
Nowadays, we are witnessing changes in the traditional clinical trial landscape: many methods have b...